ImmPACT Bio to Participate at the 2024 Cell and Gene Meeting on the Med Conference

/PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR)...

Related Keywords

Rome ,Lazio ,Italy ,Sumant Ramachandra ,Prnewswire Immpact Bio United States Inc , ,Bio United States ,Gene Meeting ,Targeting Autoimmune Disease ,Immpact Bio Usa Inc ,